Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity

Publikasjonsdetaljer

• Journal: EBioMedicine, vol. 57, p. 0, 2020
• Utgiver: Elsevier
• Internasjonale standardnumre:
  • Trykt: 2352-3964
  • Elektronisk: 2352-3964
• Lenker:
  • ARKIV: http://hdl.handle.net/10852/83780
  • DOI: doi.org/10.1016/j.ebiom.2020.102841